MedTech Dive March 25, 2025
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.
Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference.
Dexcom pointed to data claiming its updated CGM is the most accurate. The results show a mean absolute relative difference of 8% — a widely used measurement comparing CGM results to blood glucose readings. Dexcom has submitted an application for the 15-day sensor to the Food and Drug Administration for clearance.
Using technology to manage Type 2 diabetes was also a focus at the conference. Dexcom shared results of a survey...
Today's Sponsors
Today's Sponsor
